Risk of microvascular complications over 30 years in latent autoimmune diabetes of adults compared with type 2 diabetes

Risk of microvascular complications over 30 years in latent autoimmune diabetes of adults compared with type 2 diabetes

Détails bibliographiques
Auteurs principaux:	Maddaloni, E, Coleman, R, Agbaje, O, Buzzetti, R, Holman, R
Format:	Conference item
Langue:	English
Publié:	Springer 2019

Documents similaires

Serum sclerostin and bone turnover in latent autoimmune diabetes in adults
par: Napoli, N, et autres
Publié: (2018)

An association analysis of the HLA gene region in latent autoimmune diabetes in adults.
par: Desai, M, et autres
Publié: (2007)

Genetic and immunological characterisation of patients with latent autoimmune diabetes in adults (LADA)
par: Desai, M, et autres
Publié: (2005)

Susceptibility effects of variation at the IDDM2 (Insulin-gene) locus in latent autoimmune diabetes in adults (LADA).
par: Desai, M, et autres
Publié: (2003)

Simulating the impact of targeting lower systolic blood pressure and LDL-cholesterol levels on type 2 diabetes complication rates
par: Mostafa, S, et autres
Publié: (2018)

Ocular microvascular complications in diabetic retinopathy: insights from machine learning
par: Ahmed, Thiara S., et autres
Publié: (2024)

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.
par: Stratton, I, et autres
Publié: (2000)

The variable number of tandem repeats upstream of the insulin gene is a susceptibility locus for latent autoimmune diabetes in adults.
par: Desai, M, et autres
Publié: (2006)

Comparison of adults with insulin resistance (IR) in latent autoimmune diabetes versus IR in glutamic acid decarboxylase antibody-negative diabetes
par: Salem, S.D., et autres
Publié: (2014)

Microvascular outcomes in type 2 diabetes - Authors' reply
par: Zoungas, S, et autres
Publié: (2017)

FPG and HbA(1c) are independent risk factors for microvascular but not macrovascular complications in newly diagnosed type 2 diabetes
par: Kim, J, et autres
Publié: (2005)

Diabetes‐induced microvascular complications at the level of the spinal cord; a contributing factor in diabetic neuropathic pain
par: Ved, NK, et autres
Publié: (2018)

First genome-wide association study of latent autoimmune diabetes in adults reveals novel insights linking immune and metabolic diabetes
par: Cousminer, Diana L., et autres
Publié: (2020)

Diabetic microvascular complications as simple indicators of risk for cardiovascular outcomes and heart failure
par: Preiss, D, et autres
Publié: (2016)

The UK Prospective Diabetes Study: celebrating 30 years - Introduction
par: Holman, R, et autres
Publié: (2008)

Variation at the insulin VNTR locus but not the CTLA-4 locus is associated with age of onset and need for insulin therapy in latent autoimmune diabetes in adults (LADA)
par: Horton, V, et autres
Publié: (2001)

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study.
par: Adler, A, et autres
Publié: (2000)

Microvascular and macrovascular disease in subjects with increased but not diabetic fasting glucose levels
par: Karunakaran, S, et autres
Publié: (1996)

Predicting post one-year durability of glucose-lowering monotherapies in patients with new-onset type 2 diabetes
par: Agbaje, O, et autres
Publié: (2017)

Prevalence of diabetes in pregnancy and microvascular complications in native Indonesian women: The Jogjakarta diabetic retinopathy initiatives in pregnancy (Jog-DRIP)
par: Widyaputri, Felicia, et autres
Publié: (2022)

Modelling incremental benefits on complications rates when targeting lower HbA1c levels in people with Type 2 diabetes and cardiovascular disease
par: Mostafa, SA, et autres
Publié: (2017)

GAD autoantibodies and epitope reactivities persist after diagnosis in latent autoimmune diabetes in adults but do not predict disease progression: UKPDS 77.
par: Desai, M, et autres
Publié: (2007)

Relationship of autoantibodies to glutamic acid decarboxylase (GADA) to deterioration of glycamic control assessed by therapy progression in latent autoimmune diabetes in adults (LADA) in the UKPDS
par: Clark, A, et autres
Publié: (2005)

GAD65 autoantibody titres at diagnosis in Latent Autoimmune Diabetes in Adults (LADA) differ from Type 1 diabetes (T1D) and together with epitope specificity predict insulin requirement
par: Desai, M, et autres
Publié: (2004)

A clinical screening tool identifies autoimmune diabetes in adults: response to Fourlanos et al.
par: Davis, T, et autres
Publié: (2006)

Prevalence of microvascular complications in newly diagnosed type 2 diabetes mellitus in primary healthcare clinics
par: Wong, Wan Ling, et autres
Publié: (2020)

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.
par: Stearne, MR, et autres
Publié: (1998)

Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group.
par: Stearne, MR, et autres
Publié: (1998)

Impact of the metabolic syndrome on macrovascular and microvascular outcomes in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study 78.
par: Cull, C, et autres
Publié: (2007)

Susceptibility for latent autoimmune diabetes in adults (LADA) is determined by variation at the 1DDM2 (insulin-gene) locus in white Caucasian patients from UK repositories
par: Desai, M, et autres
Publié: (2005)

Polygenic control of autoimmune diabetes in nonobese diabetic mice.
par: Ghosh, S, et autres
Publié: (1993)

Sulphonylurea therapy over six years does not delay progression to diabetes
par: Herlihy, O, et autres
Publié: (2000)

Insulin VNTR and HLA DRB1/DQB1 LOCI affect age of presentation of autoimmune diabetes in adults
par: Horton, V, et autres
Publié: (1998)

An improved model to estimate lifetime health outcomes of patients with type 2 diabetes using 30-year follow-up data from the United Kingdom prospective diabetes study
par: Hayes, A, et autres
Publié: (2011)

Annexin A1 attenuates microvascular complications through restoration of Akt signalling in a murine model of type 1 diabetes
par: Purvis, G, et autres
Publié: (2017)

United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus.
par: Turner, R, et autres
Publié: (1996)

United Kingdom prospective diabetes study 17: A 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus
par: Turner, R, et autres
Publié: (1996)

Possible prevention of type 2 diabetes with acarbose or metformin over three years
par: Citroen, H, et autres
Publié: (2000)

Final adult height and its relationship to blood glucose control and microvascular complications in IDDM.
par: Penfold, J, et autres
Publié: (1995)

The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65).
par: Clarke, P, et autres
Publié: (2003)